Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction

A. Christian Held, Joel M. Gore, John Paraskos, Linda A. Rape, Steven P. Ball, Jeanne M. Corrao, Joseph S. Alpert

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Left ventricular (LV) mural thrombi have long been recognized as a complication of acute myocardial infarction (AMI). Recent echocardiographic studies suggest an incidence of 2 to 18% in patients with AMI. Anterior infarctions are found to have a much higher incidence of mural thrombus than inferior infarctions.1 Previous reports have noted conflicting results regarding the effect of thrombolysis on the formation of LV mural thrombi after AMI.2-4 The aim of this study was 2-fold: to examine if systemic thrombolytic therapy using either tissue plasminogen activator or streptokinase reduces the incidence of LV mural thrombi early after AM1 compared with conventional treatment, and to determine if reperfusion of the infarct-related artery was associated with a lower incidence of LV mural thrombi.

Original languageEnglish (US)
Pages (from-to)310-311
Number of pages2
JournalThe American Journal of Cardiology
Volume62
Issue number4
DOIs
StatePublished - Aug 1 1988
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction'. Together they form a unique fingerprint.

  • Cite this